Infection and Immunity, December 2000, p. 6526-6534, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
-Oligosaccharide Phenotype of
Neisseria gonorrhoeae Strain MS11 on Invasion of Chang
Conjunctival, HEC-1-B Endometrial, and ME-180 Cervical Cells
Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York 10021,1 and Department of Biology, The Catholic University of America, Washington, D.C. 200642
Received 24 February 2000/Returned for modification 15 May 2000/Accepted 24 August 2000
| |
ABSTRACT |
|---|
|
|
|---|
The genes encoding the glycosyltransferases responsible for the
addition of the five sugars in the
-oligosaccharide (
-OS) moiety
of lipooligosaccharide (LOS) have been identified. Disruption of these
glycosyltransferase genes singly or in combination results in
corresponding truncations in LOS. In the present work we show that
sequential deletion of the terminal four sugar residues of gonococcal
-OS had no discernible effect on the invasion of human conjunctival,
endometrial, and cervical cell lines. However, deletion of the proximal
glucose, which resulted in the complete deletion of
-OS,
significantly impaired invasion of the gonococci into all three cell
lines. The effect of deleting
-OS on invasion was independent of and
additive to the known invasion-promoting factor OpaA. These data
suggest that the proximal glucose residue of the
-OS chain of LOS is
required for efficient invasion of gonococci into host mucosa.
| |
INTRODUCTION |
|---|
|
|
|---|
Neisseria gonorrhoeae (the gonococcus [GC]), a gram-negative bacterium that naturally infects only humans, is the causative agent of gonorrhea. Gonorrhea is one of the more prevalent sexually transmitted diseases, with more than 600,000 cases reported every year in the United States (82). Currently, no gonococcal vaccine is available, mainly due to the high frequency of phase and antigenic variation of GC surface structures.
Early in vitro studies of GC invasion were done with fallopian tube explants obtained from patients undergoing surgical sterilization or hysterectomy. In this model it was shown that GC are internalized by nonciliated cells and sequestered within membrane-bound vacuoles which transcytose, fuse with the cells' basolateral membranes, and release the bacteria into the submucosa (22, 26, 39-41, 80), where they can initiate an inflammatory reaction and invade the bloodstream to spread systemically.
Most of the recent in vitro studies of GC adherence and invasion have been done with cell lines. Internalization by epithelial cells requires viable GC (52) and occurs by a process termed parasite-directed endocytosis (38). This mechanism is reminiscent of classical phagocytosis (which is microfilament dependent and thus inhibited by the cytochalasins), but differs in that it occurs in ordinarily nonphagocytic cells and appears to be initiated by bacterial rather than host cell factors. There is evidence from studies using cell lines as well as direct examination of urethral discharge that intracellular GC reside both within vacuoles and free in the cytoplasm (43, 64, 81).
Three GC surface structures of particular relevance to the initiation
of GC infection include pili, opacity (Opa) proteins, and
lipooligosaccharide (LOS). Pili are filamentous outer membrane appendages that cause an initial attachment of GC to epithelial and
endothelial cells (55, 56, 69, 78) via human membrane cofactor protein CD46 (30). GC recovered from the urethras
of infected male human volunteers form piliated colonies exclusively, indicating a role in the initiation of the infection in vivo
(73). Furthermore, extensive antigenic variation of pilus
components occurs by a variety of mechanisms (17, 27)
throughout the course of both natural and experimental infections
(63, 73), allowing immune evasion and tissue tropism.
Efficient invasion of some human epithelial cells by GC occurs in the
nonpiliated (P
) rather than the pillated (P+)
phase (23, 35).
Opacity (Opa) proteins are a family of GC outer membrane proteins that
mediate tight adherence to and invasion of host cells (3, 5, 14,
32, 65). There are 11 different complete Opa genes in GC strain
MS11, with antigenic variation being determined by which Opa proteins
happen to be turned on or off in a particular GC (6). This
phase variation of individual Opa proteins occurs at a frequency of
~10
3 and is mainly controlled at the translational
level by a recA-independent slipped-strand mispairing
mechanism (4, 6, 37, 44, 68). It has been shown that OpaA
mediates efficient GC strain MS11 invasion of Chang conjunctival,
HEC-1-B endometrial, and ME-180 cervical human epithelial cell lines
(32, 35). Adherence of OpaA+ GC and their
internalization by epithelial cells is mediated through the binding of
OpaA to epithelial heparan sulfate proteoglycans (9, 20,
77).
Neisseria gonorrhoeae expresses (LOS), which lacks the
O-antigen sugar repeats present in the lipopolysaccharides (LPS) of enteric bacteria. GC LOS consists of lipidA, which is embedded in the
outer membrane and attached to two 2-keto-3-deoxy-mannooctulosonic acid
(KDO) molecules. Attached to the first KDO residue are two heptoses
carrying the
-,
-, and
-oligosaccharide chains (Fig. 1); this is in contrast with enteric LPS,
which contains a single oligosaccharide chain. Schneider et al.
challenged human volunteers with GC strain MS11 var A, which
predominantly expresses a lactosyl group as its
-oligosaccharide
(
-OS) (31), and found that the majority of the variants
recovered after the onset of dysuria and discharge expressed
higher-molecular-weight LOS molecules (60). An isolate with
the full-length
-OS was named variant C (var C) (60) and
is the parental variant we chose for this study. LOS varies
independently of other GC surface structures (including Opa proteins
and pili) at a frequency of ~10
3 in the absence of
selective pressures (1, 61).
|
The genes encoding the glycosyltransferases responsible for the
stepwise addition of each sugar to gonococcal
-OS have been identified and are labeled in Fig. 1. The lgtA to
lgtE genes are located in a single cluster (Fig.
2A) that is not adjacent to other LOS
synthesis genes. Four of the genes (lgtA, -B, -D, and -E) encode the glycosyltransferases that add the four
terminal sugars of
-OS, whereas lgtC encodes the
-galactosyltransferase responsible for the alternative
-chain
(19). lgtA (lsi-2) was also
independently identified by Danaher et al. (12). lgtA, -C, and -D can phase vary due to the presence of
poly(G) tracts within the gene sequences; these nucleotide repeats can
cause slipped-strand errors in replication, resulting in translational frameshifts (7, 12, 19, 24, 85). lgtF encodes the
glycosyltransferase that adds the proximal Glc of
-OS to Hep1; it is
located immediately upstream of rfaK, which adds the
-chain (Fig. 1 and 2B). The two genes are cotranscribed, and this
operon has been named ice, for inner core extension
(29). lgtF was previously identified in the
meningococcus (MC) (29), and we subsequently cloned the GC
homolog (this study).
|
Disruption of the
-OS glycosyltransferase genes singly or in
combination results in the stable expression of truncated LOS, as
evidenced by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), immunochemical, and structural analyses (19, 29, 79; this study). Data presented herein specifically address the effect of these stable truncations in the
-OS of LOS on the interaction of N. gonorrhoeae strain MS11 with Chang
conjunctival, HEC-1-B endometrial, and ME-180 cervical cells. These
cell lines represent tissues that are natural sites for infection by GC
(75). Adherence and invasion of the MS11 LOS mutants was
measured by the gentamicin selection assay (15, 35). We show
that the proximal glucose but not the terminal four sugars of
-OS is
necessary for efficient GC invasion into these cell lines.
(This study was presented in part at the 11th International Pathogenic Neisseria Conference, Nice, France, 1 to 6 November 1998.)
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents and supplies. Reagents and chemicals were obtained from Sigma Chemical Co. (St. Louis, Mo.) or Fisher Scientific (Springfield, N.J.). Restriction enzymes and prestained molecular weight markers were purchased from New England Biolabs (Beverly, Mass.). Tissue culture plates were purchased from Falcon (Franklin Lakes, N.J.). Tissue culture medium was purchased from Gibco-BRL (Grand Island, N.Y.), and fetal bovine serum (FBS) was purchased from Hyclone Laboratories, Inc. (Logan, Utah).
Bacterial strains.
The parental wild-type (wt) strain used
was N. gonorrhoeae MS11 var C, a recent human-passaged
strain that expresses full-length LOS (60). GC strain MS11
expressing wt or truncated forms of LOS were either stored at
70°C
in Greave's solution (5% monosodium glutamate and 5% bovine serum
albumin in sterile distilled water) or passed daily on GC agar
supplemented with 1% IsoVitaLex (70) and then incubated at
37°C in 6% CO2. Escherichia coli strain HB101
was stored at
70°C in Greave's solution or passed on Luria agar
and then incubated at 37°C in 6% CO2. The GC were
monitored for piliation by viewing colony morphology under a dissecting microscope (72) and for expression of the invasion-promoting OpaA by colony morphology (35, 70, 71), SDS-PAGE, and
Western blotting.
Protein electrophoresis and immunoblotting. GC were grown overnight on GC agar plates; opaque colonies were analyzed to verify OpaA expression, and transparent colonies were analyzed to verify lack of detectable Opa protein expression. The colonies were suspended in Laemmli buffer (33) and heated at 100°C for 5 min; the lysates were then subjected to SDS-PAGE. The Opa proteins were also detected by SDS-PAGE and immunoblotting (74) using rabbit polyclonal anti-OpaA antiserum (3) as the primary antibody, with alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin (Sigma) as the secondary antibody. The blot was developed with 5-bromo-4-chloro-3-indolylphosphate and p-nitro blue tetrazolium chloride in a Tris-MgCl2 buffer. GC subcultured and stored in frozen aliquots for further study expressed either OpaA or no detectable Opa proteins and were either piliated or nonpiliated.
Electrophoretic analysis of LOS. GC, either swabbed from GC agar plates or pelleted from culture in proteose peptone liquid medium (19), were suspended in sample buffer, heated at 100°C for 5 min, and incubated with proteinase K (~500 µg/ml) for 1 h at 55°C. LOS was analyzed by tricine-SDS-PAGE and silver staining (34).
Construction of pLGTA'CD
.
In order to prevent undesired
phase variation, the poly(G) tract in lgtA (Fig. 2A) was
altered by oligonucleotide-mediated mutagenesis, using the method of
Zoller et al. (86) as modified by Sambrook et al.
(57). The two primers were the M13 reverse primer and the
mutagenic primer C GAA TTG GCA AAG TCT GGA GGT GGA GAA TAT ATT GCG CGC, which was synthesized by the Rockefeller
University Technology Center. The template was a cloned copy of the wt
lgtA. As indicated by the underlined segment of the
mutagenic primer sequence, 11 G's [equivalent to the poly(G) tract in
GC strain MS11 lgtA (85)] were replaced with
thymine or adenine in the third position of the codons in the reading
frame; thus, the gene's poly(G) tract was eliminated, in effect
locking lgtA into an on position by abolishing its ability
to phase vary without affecting the amino acid sequence. E. coli cells containing a plasmid with the mutated sequence were
identified by colony hybridization with the mutagenic primer labeled
with 32P (57). The mutated lgtA gene
was verified by DNA sequencing and renamed lgtA'. The
deletion of lgtC and lgtD (Fig. 2A) was accomplished by digesting a plasmid containing the complete
lgt locus with Tth111I and religating to create
pLGTACD
; this mutation removed a DNA segment consisting
of 635 nucleotides from the 3' end of lgtC plus 462 nucleotides from the 5' end of lgtD. Subsequently, the
mutated lgtA' was substituted for the wild-type
lgtA in pLGTACD
by subcloning to yield pLGTA'CD
.
Construction of pNGLGTF::erm.
An Neisseria
menigitidis lgtF amplicon was generated by a PCR protocol using MC
strain BNCV genomic DNA as the template and MC lgtF primers
CK23 and CK24 (29). The CK23-CK24 lgtF amplicon was labeled with enhanced chemiluminescence (Amersham-Pharmacia) and
used to probe a GC strain 15253-
ZapII phage library by plaque hybridization (2). This screen yielded a phagemid clone,
pGCLGTF, containing 626 bp of the ~750-bp lgtF gene as
well as a ~6-kb upstream sequence. In order to disrupt
lgtF, pGCLGTF was digested with BsiWI at 493 nucleotides into the lgtF gene fragment and filled with
Klenow enzyme; a 789-bp erythromycin (erm) resistance cassette (19) was then inserted into this site (Fig. 2B).
The resultant plasmid, named pGCLGTF::erm, was further
modified in four sequential steps. First, it was reduced in size from
9,902 to 6,927 bp by digestion with EcoRV, which removed
~3 kb of the DNA sequence upstream of lgtF. Second, the
erm gene was reversed by cutting out the cassette with
BsiWI, religating the fragments, and selecting a clone with
the erm gene inverted to the same orientation as
lgtF. Third, the erm transcriptional terminator
and the downstream, incomplete 133-bp lgtF 3' sequence were
removed by digestion with Ppu10I and SpeI.
Fourth, a 1.2-kb amplicon (generated from GC strain FA1090 genomic DNA
using lgtF and rfaK primers) consisting of the
complete 265-bp 3' end of lgtF plus the entire
rfaK gene was subcloned into the Ppu10I and
SpeI sites to obtain the recombination substrate vector
pNGLGTF::erm.
-chain) was determined by carbohydrate analysis of MS11 lgtF LOS by high-pH
anion-exchange chromatography (2, 16), confirming the
nonpolar nature of the mutation (data not shown).
Generation of MS11 LOS mutants.
Plasmids carrying the
lgtABCD
, lgtABCDE
, and lgtF
mutations (Fig. 2), which conferred erythromycin resistance, were
purified from E. coli XL1-Blue MRF' by alkaline lysis,
verified by restriction analysis, and used to transform MS11 var C
(OpaA+ P+) by means of the spot dilution method
(13). In brief, the GC colonies (16 to 18 h old) grown
on GC agar were suspended and diluted in proteose peptone liquid medium
to ~104 CFU/ml. Fresh GC agar was spread with 200 µl of
the final dilutions and then spotted with 20 µl of plasmid
preparations (~1 mg/ml). Plates were incubated at 37°C in 6%
CO2 for 30 h to allow transformation, recombination, expression of phenotypic markers, and colonial growth. Colonies were picked from the plasmid-containing areas and then passed thrice on GC agar containing erythromycin (2 µg/ml) for identification of transformants. Plasmid pLGTA'CD
was
purified from E. coli XL1-Blue MRF' and used to transform
the erythromycin-resistant MS11 lgtABCDE
(OpaA+ P+) by means of the spot dilution
technique. Colonies were picked from the plasmid-containing areas and
passed twice on GC agar; transformants were chosen by screening for
sensitivity to erythromycin (2 µg/ml). The MS11 LOS mutants were
analyzed for LOS and opacity phenotypes.
Comparison of growth rates. Nonpiliated wt and LOS mutant GC grown for ~18 h on GC agar plates were suspended in proteose peptone broth to an optical density (OD) of 0.3 at 540 nm. Suspensions were diluted 1:10 into fresh proteose peptone broth supplemented with 1% IsoVitaLex and grown at 37°C in a shaker incubator. The OD540 of each culture was measured at 1-h intervals.
Cell culture. Chang conjunctival cells (ATCCCCL 20.2), HEC-1-B endometrial cells (ATCC HTB 113), and ME-180 cervical cells (ATCC HTB 33) were maintained in RPMI 1640 medium plus 1 mM sodium pyruvate and 5% FBS in tissue culture flasks incubated at 37°C in 6% CO2.
Adherence and invasion assays. The gentamicin survival assay was used to measure adherence and invasion (15, 35). We confirmed the susceptibility of our MS11 LOS mutants to gentamicin by their lack of growth on GC agar containing gentamicin (100 µg/ml). For infection experiments, monolayers were grown in RPMI 1640 plus 1 mM sodium pyruvate and 5% FBS in 24-well tissue culture plates. Confluent epithelial cell monolayers, obtained after 24 h of incubation of ~2 × 105 epithelial cells per well at 37°C in 6% CO2, were determined to contain ~4 × 105 epithelial cells per monolayer. Immediately before use, the monolayers were rinsed once with RPMI 1640 medium with no FBS.
Wt and LOS mutant GC (nonpiliated and expressing either OpaA or no detectable Opa protein) were grown for ~18 h on GC agarose plates (76) at 37°C in 6% CO2 and then suspended in proteose peptone broth to an OD540 of 0.3 (~2 × 108 CFU/ml). One hundred microliters (~2 × 107 CFU) of the appropriate suspension was added to 1 ml of FBS-free RPMI medium (76) per Chang conjunctival cell monolayer in 24-well tissue culture plates and incubated for 5 h at 37°C in 6% CO2. For the cytochalasin D inhibition experiments, 1 ml of fresh RPMI medium containing either 10 µg of cytochalasin D (10 µl of a 1-mg/ml solution in dimethyl sulfoxide [DMSO]) per ml or 10 µl of DMSO (as a control) was added to appropriate monolayers, which were then incubated for 30 min prior to infection. After the inoculation and a 5-h incubation, the monolayers were washed three times in phosphate-buffered saline (PBS) to remove non-cell-associated bacteria. In some assays, equal-volume samples of the different mutants were taken and plated from the cell culture medium just prior to removing non-cell-associated bacteria and verified to yield similar numbers of colonies. To measure total cell association (a combination of adherent and invasive bacteria), infected monolayers were lysed with 1 ml of saponin (1% in PBS) for 15 min at 37°C. To measure invasion, infected monolayers were incubated further with gentamicin (100 µg/ml) in RPMI for 1 h (a step which kills extracellular bacteria, while internalized bacteria survive), then washed and lysed. Appropriate dilutions were made and plated on GC agar for CFU counts; in some assays, dilutions were also plated on agar containing gentamicin (100 µg/ml) to verify susceptibility. Monolayers were inoculated in triplicate, and each experiment was performed at least three times. Because the consolidated data from repeated experiments done at different times did not follow a Gaussian distribution, we used a generalized Friedman-type statistical procedure which ranks all the data points within each experiment and then compares the average sum of ranks between groups in a set of experiments; this nonparametric test has been modified to handle unbalanced designs, tied values, and values that are off scale or missing at random (83, 84).| |
RESULTS |
|---|
|
|
|---|
Disruption of the lgt genes in GC strain MS11 leads to
expression of truncated LOS.
N. gonorrhoeae strain MS11
var C is a recent human-passaged strain that expresses full-length
LOS (60). Our repertoire of LOS mutants (Table
1) was created by
transformation-recombination of MS11 var C
(OpaA+ P+) with plasmids carrying the
lgtA'CD
, lgtABCD
, lgtABCDE
, or lgtF
mutation (Fig. 2). Sequential deletion of the LOS glycosyltransferase genes was predicted to result in the expression of progressively shorter LOS chains. Accordingly, as shown in Fig.
3, the LOS bands migrated by SDS-PAGE in
a manner consistent with their relative sizes, with the band
corresponding to MS11 var C (wt) migrating the shortest distance and
the LOS band corresponding to MS11 lgtF (completely lacking
-OS) migrating the longest distance. This also provided evidence
that none of the mutants underwent spontaneous slippage in the poly(C)
tract of lgtG to an in-frame position, which would have
resulted in expression of the
-chain (see Fig. 1). Furthermore, the
truncations of LOS had no discernible effect on the growth rate of GC
in liquid medium (data not shown).
|
|
GC strain MS11 LOS mutants are unaltered in expression of
OpaA.
Wt and LOS mutant GC (Table 1) used for study were
nonpiliated (because pili are known to interfere with GC invasion in
vitro) and expressed either OpaA or no detectable Opa proteins
(35). Expression of the ~30-kDa OpaA was similar by
SDS-PAGE analysis in GC expressing wt or mutant LOS (Fig.
4A, lanes 2 to 6). The identity of OpaA
was further confirmed for the lgtF mutant by Western
blotting with polyclonal anti-OpaA antiserum (Fig. 4B), which
recognized OpaA in extracts from E. coli expressing
recombinant OpaA, MS11 var C (OpaA+), and MS11
lgtF (OpaA+) (lanes 3 to 5) but not in extracts
from E. coli carrying a plasmid control (lane 2) and MS11
var C (Opa
) (lane 6).
|
Only complete truncation of MS11
-OS impairs GC invasion into
human epithelial cell lines.
Cell association and invasion of the
MS11 LOS mutants (Table 1) into Chang conjunctival, HEC-1-B
endometrial, and ME-180 cervical cells were measured by the gentamicin
survival assay (15, 35). Gentamicin is an aminoglycoside
which does not readily permeate eukaryotic cell membranes; thus,
internalized bacteria are shielded from the bactericidal effects of
this antibiotic (15). Total cell association is a measure of
the combination of adherent and invasive bacteria. In our hands, the
proportion of gentamicin-resistant organisms was only ~1% of the
measurement of cell association; thus, total cell association provided
a good estimate of adherence, and we hereafter use the terms interchangeably.
,
lgtABCD
, and lgtABCDE
(Table 1) into Chang,
HEC-1-B, and ME-180 cell lines to be comparable to those of the wt
(Fig. 5, P > 0.1). In contrast, MS11 lgtF (Table 1) was significantly less
invasive (Fig. 5, P
0.05) in these cell lines. This
mutant was also consistently but only slightly less adherent than wt,
with statistical significance being reached in ME-180 cells (Fig. 5C,
P < 0.05) but not in Chang (Fig. 5A, P > 0.1) or HEC-1-B (Fig. 5B, P > 0.1) cells. As
expected, in the Chang (Fig. 5A), HEC-1-B (Fig. 5B), and ME-180 (Fig.
5C) cell lines, the negative control MS11 var C (Opa
) was
significantly less adherent (P < 0.05) and invasive
(P < 0.001) than the positive control MS11 var C
(OpaA+). These results suggest that the presence of the
proximal glucose of the
-chain (added by the glycosyltransferase
LgtF) is indispensable for efficient invasion into all three cell lines
and has a significantly greater effect on invasion than on adherence in
Chang and HEC-1-B cells.
|
-OS glucose and OpaA have an additive effect on the invasion of
Chang conjunctival and ME-180 cells.
A relevant question that we
sought to address is whether Opa and LOS (
-chain) act sequentially
in a single pathway or via independent parallel pathways. To this end,
we determined whether the lgtF mutation in an
Opa
background would cause levels of invasion even lower
than with MS11 var C (Opa
) (Table 1) in Chang
conjunctival and ME-180 cervical cells. A sequential, OpaA-dominant
pathway would be expected to result in no further reduction in invasion
by MS11 lgtF (Opa
) (Table 1). In contrast, we
found that (in the absence of cytochalasin D), MS11 lgtF
(Opa
) was less invasive than MS11 var C
(Opa
) in Chang cells (Fig.
6A, P < 0.05) and also
in ME-180 cells, though this latter P value did not quite
reach significance (Fig. 6B, P = 0.09). In ME-180
cells, MS11 lgtF (Opa
) was also less invasive
than MS11 lgtF (OpaA+) (Fig. 6B,
P < 0.05). These data argue for two independent
pathways rather than one sequential pathway, since the absence of both OpaA and the LOS
-chain (proximal glucose) caused a greater
reduction in invasion than did either property alone.
|
Cytochalasin D inhibits invasion of MS11 var C (OpaA+) and MS11 lgtF (OpaA+) into Chang and ME-180 cells. GC invasion is dependent upon actin polymerization, which is inhibited by cytochalasin D (5, 64). As expected, cytochalasin D significantly inhibited invasion of MS11 var C (OpaA+) (Table 1) in Chang conjunctival cells (Fig. 6A, P < 0.001) and ME-180 cells (Fig. 6B, P < 0.001). MS11 lgtF (OpaA+) (Table 1) was likewise significantly inhibited by cytochalasin D in ME-180 cells (Fig. 6B, P = 0.001). These results confirmed that optimum OpaA-mediated invasion by both MS11 var C and MS11 lgtF is dependent upon actin polymerization.
Invasion by MS11 var C (Opa
) (Table 1) was significantly
inhibited by cytochalasin D in both Chang conjunctival cells (Fig. 6A,
P < 0.05) and ME-180 cells (Fig. 6B, P < 0.01). In contrast, cytochalasin D significantly inhibited the
invasion of MS11 lgtF (Opa
) (Table 1) into
ME-180 cells (Fig. 6B, P < 0.01) but not into Chang
conjunctival cells (Fig. 6A, P > 0.5). It is possible
that the very small numbers of bacteria recovered from the MS11
lgtF (Opa
) invasion experiments included
adherent GC that were gentamicin tolerant due to being sequestered
within folds of the eukaryotic membrane and shielded from the effects
of the antibiotic; alternatively, the recovery could represent invasion
through another pathway not inhibited by cytochalasin D.
| |
DISCUSSION |
|---|
|
|
|---|
Our aim was to determine the effect of GC
-OS phenotype on GC
interaction with Chang conjunctival, HEC-1-B endometrial, and ME-180
cervical cells, three human cell lines relevant to GC pathogenesis (75). We found that sequential deletion of the terminal four sugar residues of the
-OS in N. gonorrhoeae strain MS11
had no discernible effect on the bacterium's adherence to or invasion of these cell lines. In contrast, the effect of the nonpolar
lgtF mutation (complete deletion of the
-chain but no
discernible effect on expression of the
-chain) was quite marked,
with a slight reduction in adherence but a much greater (10- to
100-fold) reduction in invasion into all three cell types. These
results suggest that the proximal glucose of the LOS
-chain plays an important role in the establishment of the mucosal infection.
We found a 5- to 10-fold lower uptake of wt GC into ME-180 cells
compared to Chang conjunctival cells; this contrasts with the results
of Kupsch et al. (32), who demonstrated a higher uptake of
the bacteria into ME-180 cells than into Chang conjunctival cells. The
reason for our contrasting results is unclear but could be due to
different culture conditions
for example, growth of the GC on agarose
plates and the use of serum-free medium for the invasion assays, both
of which have been demonstrated to increase the rate of invasion into
Chang conjunctival cells (76).
It is likely that GC do utilize more than one eukaryotic
uptake pathway. For example, our data and the results of
Grassmé et al. (21) confirmed the role of actin
polymerization in invasion by demonstrating that cytochalasin D causes
a
90% inhibition of GC internalization by Chang conjunctival cells.
Actin polymerization (as measured by inhibition of invasion by
cytochalasin D) is also required for optimum GC entry into HeLa
cervical cells (5), HEC-1-B endometrial cells
(8; this study), and ME-180 cervical cells
(21; this study). However, it has also been found that inhibitors of microtubule assembly moderately decrease GC invasion into
Chang conjunctival cells (21) and baby hamster kidney cells (52). This suggests a major requirement for a functional
actin-based microskeleton, with some contribution from the microtubular network.
The cloning of the GC lgtA to lgtF genes allowed
the construction of defined and stable
-OS mutants. Previously,
other kinds of mutants expressing truncated forms of LOS were studied.
For example, Robertson et al. cloned the GC galE gene, which
encodes the metabolic enzyme UDP-galactose-4-epimerase (53).
Because GC are unable to take up exogenous galactose, the
galE mutant cannot incorporate galactose into its LOS and
expresses an
-OS which consists of one sugar, the proximal glucose.
Interestingly, this MS11 galE mutant of Robertson et al. has
a structure similar to that of our MS11 lgtABCDE
(Table 1) and likewise exhibits wt levels of adhesion to and invasion
of epithelial cells (53; this study). In contrast, a
disruption of the GC lsi-1/rfaF gene leads to the production
of LOS that is truncated beyond
-OS and into the inner-core region
(18, 46, 47, 62) (Fig. 1), and Schwan et al. showed that
this markedly reduces the invasion of Chang conjunctival cells by the
OpaA+ and nonpiliated lsi-1 mutants
(62). It is noteworthy that such a mutation in LOS could be
linked to a clear defect in interaction with epithelial cells despite
GC expression of an invasion-promoting Opa protein. Indeed, our study
is the first in which a series of defined and stable LOS mutants were
generated, the effect of truncations in
-OS on invasion were
systematically tested, and the proximal glucose (added by the product
of lgtF) was pinpointed as the specific residue in LOS that
is likely to play a critical role in the initiation of GC infection of
the host mucosa.
It is improbable that the lgtF mutation causes a nonspecific
disruption in the GC membrane that would affect invasion. In E. coli and Salmonella spp., the minimal LPS structure
required for viability consists of lipid A linked to two KDO
residues (reviewed in reference 51); however, there
is evidence of membrane perturbation in some enteric bacteria when
there is an inability to synthesize or incorporate heptoses into this
structure (45, 58). In contrast, a meningococcal
lpxA mutant (which is defective in the first committed step
in lipid A biosynthesis and lacks detectable LOS) is viable and
exhibits normal cell envelope ultrastructure but a reduced growth rate
(67). Thus, the absence of the LOS
-chain alone would not
be expected to adversely affect GC membrane integrity; indeed, we found
that the lgtF mutation had no effect on GC growth rate in
liquid culture (data not shown).
E. coli cells expressing recombinant OpaA (rOpaA) adhere to
(10, 21) but do not invade (21) Chang
conjunctival cells, indicating that OpaA alone is insufficient to
mediate invasion into this cell type. Kupsch et al. found that E. coli (rOpaA+) showed poor adherence to and invasion of
HEC-1-B and ME-180 cells (32). These results indicate that
some bacterial factor(s) other than Opa may also be involved in the
internalization of GC by human epithelial cells. Indeed, Song et al.
have recently demonstrated that GC expressing both pili and full-length
-OS can efficiently invade human epithelial cells in the absence of detectable Opa proteins (66). Accordingly, we have here
presented evidence that the proximal glucose of
-OS is a component
essential to the efficient invasion of GC into three physiologically
relevant human cell lines: Chang conjunctival, HEC-1-B endometrial, and ME-180 cervical cell monolayers. We also showed data suggesting that GC
OpaA and
-OS glucose operate via independent pathways.
Among the many questions that now need to be addressed are the following. First, what is the epithelial receptor for GC LOS? Many possibilities exist. It is known that GC LOS structures mimic an array of human epithelial glycosphingolipids (reviewed in reference 36). Also, researchers have reported the binding of GC LOS to a 70-kDa eukaryotic protein found on HepG2 cells (50). Additionally, Pier et al. showed that cystic fibrosis transmembrane conductance regulator is a receptor for Pseudomonas aeruginosa LPS that mediates the internalization of the bacteria by lung epithelial cells (48, 49). It is intriguing that a pseudomonal algC mutant, which resembles our MS11 lgtF mutant in lacking glucose in the core of its LPS (11, 54) (Table 1), is significantly less invasive than P. aeruginosa possessing a complete outer oligosaccharide core (49).
Another relevant question is whether the MS11 lgtF mutant
is attenuated in vivo. Results of our in vitro experiments
showed that MS11 lgtABCD
(Table 1) was comparable
to MS11 var C in adherence and invasion (Fig. 5). In contrast,
Schneider et al. found that MS11 var A, which, like MS11
lgtABCD
, expresses a lactosyl-LOS (31) (Table
1), was not as infectious as MS11 var C in clinical trials
(59). Furthermore, when symptoms of gonorrhea ensued
subsequent to inoculation of volunteers with MS11 var A, var C
organisms were recovered in higher proportions than the expected
(10
3) frequency of variation (59, 60). It
would thus be interesting to compare the infectiousness of our
repertoire of defined and stable MS11 LOS mutants in clinical trials.
Such studies would further clarify the specific nature of the
contribution of GC LOS to the establishment of the GC infection.
| |
ACKNOWLEDGMENTS |
|---|
We thank David Stephens and Charlene Kahler for kindly providing prepublication sequence information about the MC ice locus. The invaluable editorial assistance of John McKinney, the technical expertise of Clara Eastby and James Parker, the laboratory help of Milton Brown, and the secretarial support of Jane Berger-Hassett are much appreciated. We also gratefully acknowledge Knut Wittkowski for statistical analyses, Alice Erwin for useful suggestions, and Tie Chen for supplying E. coli HB101(pGEM3Z), E. coli HB101(pEXA), N. gonorrhoeae MS11 var C, and the polyclonal anti-OpaA antiserum.
This work was funded by PHS grants AI10615 and AI26558. S.Y.M. was supported by a GE Foundation Academic Fellowship and NIH training grants GM15317 and GM07739.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, 1230 York Avenue, New York, NY 10021. Phone: (212) 327-8610. Fax: (212) 327-8960. E-mail: ecg{at}rockvax.rockefeller.edu.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Apicella, M. A.,
M. Shero,
G. A. Jarvis,
J. M. Griffiss,
R. E. Mandrell, and H. Schneider.
1987.
Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide.
Infect. Immun.
55:1755-1761 |
| 2. |
Banerjee, A.,
R. Wang,
S. N. Uljon,
P. A. Rice,
E. C. Gotschlich, and D. C. Stein.
1998.
Identification of the gene (lgtG) encoding the lipooligosaccharide chain synthesizing glucosyl transferase from Neisseria gonorrhoeae.
Proc. Natl. Acad. Sci. USA
95:10872-10877 |
| 3. | Belland, R. J., T. Chen, J. Swanson, and S. H. Fischer. 1992. Human neutrophil response to recombinant neisserial Opa proteins. Mol. Microbiol. 6:1729-1737[Medline]. |
| 4. | Belland, R. J., S. G. Morrison, P. van der Ley, and J. Swanson. 1989. Expression and phase variation of gonococcal P.II genes in Escherichia coli involves ribosomal frameshifting and slipped-strand mispairing. Mol. Microbiol. 3:777-786[CrossRef][Medline]. |
| 5. |
Bessen, D., and E. C. Gotschlich.
1986.
Interactions of gonococci with HeLa cells: attachment, detachment, replication, penetration, and role of protein II.
Infect. Immun.
54:154-160 |
| 6. | Bhat, K. S., C. P. Gibbs, O. Barrera, S. G. Morrison, F. Jahnig, A. Stern, E. Kupsch, T. F. Meyer, and J. Swanson. 1991. The opacity proteins of Neisseria gonorrhoeae strain MS11 are encoded by a family of 11 complete genes. Mol. Microbiol. 5:1889-1901[Medline]. |
| 7. |
Burch, C. L.,
R. J. Danaher, and D. C. Stein.
1997.
Antigenic variation in Neisseria gonorrhoeae: production of multiple lipooligosaccharides.
J. Bacteriol.
179:982-986 |
| 8. | Chen, J. C. R., P. Bavoil, and V. L. Clark. 1991. Enhancement of the invasive ability of Neisseria gonorrhoeae by contact with Hec1B, an adenocarcinoma endometrial cell line. Mol. Microbiol. 5:1531-1538[CrossRef][Medline]. |
| 9. |
Chen, T.,
R. J. Belland,
J. Wilson, and J. Swanson.
1995.
Adherence of pilus Opa+ gonococci to epithelial cells in vitro involves heparan sulfate.
J. Exp. Med.
182:511-517 |
| 10. |
Chen, T., and E. C. Gotschlich.
1996.
CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins.
Proc. Natl. Acad. Sci. USA
93:14851-14856 |
| 11. |
Coyne, M. J., Jr.,
K. S. Russell,
C. L. Coyle, and J. B. Goldberg.
1997.
The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core.
J. Bacteriol.
176:3500-3507 |
| 12. |
Danaher, R. J.,
J. C. Levin,
D. Arking,
C. L. Burch,
R. C. Sandlin, and D. C. Stein.
1995.
Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation.
J. Bacteriol.
177:7275-7279 |
| 13. |
Drazek, E. S.,
D. C. Stein, and C. D. Deal.
1995.
A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.
J. Bacteriol.
177:2321-2327 |
| 14. |
Elkins, C., and R. F. Rest.
1990.
Monoclonal antibodies to outer membrane protein PII block interactions of Neisseria gonorrhoeae with human neutrophils.
Infect. Immun.
58:1078-1084 |
| 15. | Elsinghorst, E. A. 1994. Measurement of invasion by gentamicin resistance. Methods Enzymol. 236:405-420[Medline]. |
| 16. |
Erwin, A. L.,
P. A. Haynes,
P. A. Rice, and E. C. Gotschlich.
1996.
Conservation of the lipopolysaccharide synthesis locus lgt among strains of Neisseria gonorrhoeae: requirement for lgtE in synthesis of the 2C7 epitope and of the chain of strain 15253.
J. Exp. Med.
184:1233-1241 |
| 17. | Gibbs, C. P., B. Reimann, E. Schultz, A. Kaufmann, R. Haas, and T. F. Meyer. 1989. Reassortment of pilin genes in Neisseria gonorrhoeae occurs by two distinct mechanisms. Nature 338:651-652[CrossRef][Medline]. |
| 18. |
Gibson, B. W.,
W. Melaugh,
N. J. Phillips,
M. A. Apicella,
A. A. Campagnari, and J. M. Griffiss.
1993.
Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.
J. Bacteriol.
175:2702-2712 |
| 19. |
Gotschlich, E. C.
1994.
Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide.
J. Exp. Med.
180:2181-2190 |
| 20. | Grant, C. C. R., M. P. Bos, and R. J. Belland. 1999. Proteoglycan receptor binding by Neisseria gonorrhoeae MS11 is determined by the HV-1 region of OpaA. Mol. Microbiol. 32:233-242[CrossRef][Medline]. |
| 21. | Grassmé, H. U. C., R. M. Ireland, and J. P. M. van Putten. 1996. Gonococcal opacity protein promotes bacterial entry-associated rearrangements of the epithelial cell actin cytoskeleton. Infect. Immun. 64:1621-1630[Abstract]. |
| 22. | Gregg, C. R., M. A. Melly, C. G. Hellerqvist, J. G. Coniglio, and Z. A. McGee. 1981. Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J. Infect. Dis. 143:432-438[Medline]. |
| 23. |
Ilver, D.,
H. Källström,
S. Normark, and A. B. Jonsson.
1998.
Transcellular passage of Neisseria gonorrhoeae involves pilus phase variation.
Infect. Immun.
66:469-473 |
| 24. | Jennings, M. P., D. W. Hood, I. R. A. Peak, M. Virji, and E. R. Moxon. 1995. Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol. Microbiol. 18:729-740[CrossRef][Medline]. |
| 25. |
John, C. M.,
H. Schneider, and J. M. Griffiss.
1999.
Neisseria gonorrhoeae that infect men have lippooligosaccharides with terminal N-acetyllactosamine repeats.
J. Biol. Chem.
274:1017-1025 |
| 26. |
Johnson, A. P.,
D. Taylor-Robinson, and Z. A. McGee.
1977.
Species specificity of attachment and damage to oviduct mucosa by Neisseria gonorrhoeae.
Infect. Immun.
18:833-839 |
| 27. | Jonsson, A. B., G. Nyberg, and S. Normark. 1991. Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly. EMBO J. 10:477-488[Medline]. |
| 28. |
Kahler, C. M.,
R. W. Carlson,
M. M. Rahman,
L. E. Martin, and D. S. Stephens.
1996.
Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha 1,2 N-acetylglucosamine transferase (RfaK).
J. Bacteriol.
178:1265-1273 |
| 29. |
Kahler, C. M.,
R. W. Carlson,
M. M. Rahman,
L. E. Martin, and D. S. Stephens.
1996.
Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis.
J. Bacteriol.
178:6677-6684 |
| 30. | Kallstrom, H., M. K. Liszewski, J. P. Atkinson, and A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647[CrossRef][Medline]. |
| 31. | Kerwood, D. E., H. Schneider, and R. Yamasaki. 1992. Structural analysis of lipooligosaccharide produced by Neisseria gonorrhoeae, strain MS11mk (variant A): a precursor for a gonococcal lipooligosaccharide associated with virulence. Biochemistry 31:12760-12768[CrossRef][Medline]. |
| 32. | Kupsch, E., B. Knepper, T. Kuroki, I. Heuer, and T. F. Meyer. 1993. Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. EMBO J. 12:641-650[Medline]. |
| 33. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 34. | Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis, J. Immunol. Methods 126:109-117[CrossRef][Medline]. |
| 35. | Makino, S., J. P. M. van Putten, and T. F. Meyer. 1991. Phase variation of the opacity outer membrane protein controls invasion by Neisseria gonorrhoeae into human epithelial cells. EMBO J. 10:1307-1315[Medline]. |
| 36. | Mandrell, R. E., and M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187:382-402[Medline]. |
| 37. |
Mayer, L. W.
1982.
Rates of in vitro changes of gonococcal colony opacity phenotypes.
Infect. Immun.
37:481-485 |
| 38. | McGee, Z. A., G. L. Gorby, P. B. Wyrick, R. Hodinka, and L. H. Hoffman. 1988. Parasite-directed endocytosis. Rev. Infect. Dis. 10(Suppl. 2):S311-S316. |
| 39. | McGee, Z. A., A. P. Johnson, and D. Taylor-Robinson. 1981. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J. Infect. Dis. 143:413-422[Medline] |
| 40. | McGee, Z. A., M. A. Melly, C. R. Gregg, R. G. Horn, D. Taylor-Robinson, A. P. Johnson, and J. A. McCutchan. 1978. Virulence factors of gonococci: studies using human fallopian tube organ cultures, p. 258-262. In G. F. Brooks, E. C. Gotschlich, K. K. Holmes, W. D. Sawyer, and F. E. Young (ed.), Immunobiology of Neisseria gonorrhoeae. American Society for Microbiology, Washington, D.C. |
| 41. | Melly, M. A., C. R. Gregg, and Z. A. McGee. 1981. Studies of toxicity of Neisseria gonorrhoeae for human fallopian tube mucosa. J. Infect. Dis. 143:423-431[Medline]. |
| 42. |
Monod, M.,
C. Denoya, and D. Dubnau.
1986.
Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis.
J. Bacteriol.
167:138-147 |
| 43. | Mosleh, I. M., H. J. Boxberger, M. J. Sessler, and T. F. Meyer. 1997. Experimental infection of native human ureteral tissue with Neisseria gonorrhoeae: adhesion, invasion, intracellular fate, exocytosis, and passage through a stratified epithelium. Infect. Immun. 65:3391-3398[Abstract]. |
| 44. | Murphy, G. L., T. D. Connell, D. S. Barritt, M. Koomey, and J. G. Cannon. 1989. Phase variation of gonococcal protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell 56:539-547[CrossRef][Medline]. |
| 45. |
Parker, C. T.,
A. W. Kloser,
C. A. Schnaitman,
M. A. Stein,
S. Gottesman, and B. W. Gibson.
1992.
Role of the rfaG and rfaP genes in determining the lipopolysacharide core structure and cell surface properties of Escherichia coli K-12.
J. Bacteriol.
174:2525-2538 |
| 46. |
Petricoin, E. F., III,
R. J. Danaher, and D. C. Stein.
1991.
Analysis of the lsi region involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae.
J. Bacteriol.
173:7896-7902 |
| 47. |
Petricoin, E. F., III, and D. C. Stein.
1989.
Molecular analysis of lipooligosaccharide biosynthesis in Neisseria gonorrhoeae.
Infect. Immun.
57:2847-2852 |
| 48. |
Pier, G. B.,
M. Grout, and T. S. Zaidi.
1997.
Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.
Proc. Natl. Acad. Sci. USA
94:12088-12093 |
| 49. | Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaskas, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. S 271:64-67. |
| 50. | Porat, N., M. A. Apicella, and M. S. Blake. 1995. A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein Opa. Infect. Immun. 63:2164-2172[Abstract]. |
| 51. | Raetz, C. R. 1999. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, p. 1035-1063. In F. C. Neidhardt, R. I. Curtiss, J. L. Ingraham, E. C. C. Lin, and K. B. Low (ed.), Escherichia coli and Salmonella:cellular and molecular biology. ASM Press, Washington, D.C. |
| 52. |
Richardson, W. P., and J. C. Sadoff.
1988.
Induced engulfment of Neisseria gonorrhoeae by tissue culture cells.
Infect. Immun.
56:2512-2514 |
| 53. | Robertson, B. D., M. Frosch, and J. P. M. van Putten. 1993. The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol. Microbiol. 8:891-901[Medline]. |
| 54. | Rowe, P. S. N., and P. M. Meadow. 1983. Structure of the core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. Eur. J. Biochem. 132:329-337[Medline]. |
| 55. | Rudel, T., H. Boxberger, and T. F. Meyer. 1995. Pilus biogenesis and epithelial cell adherence of Neisseria gonorrhoeae pilC double knock-out mutants. Mol. Microbiol. 17:1057-1071[CrossRef][Medline]. |
| 56. | Rudel, T., J. P. M. van Putten, C. P. Gibbs, R. Haas, and T. F. Meyer. 1992. Interaction of two variable proteins (PilE and PilC) required for pilus-mediated adherence of Neisseria gonorrhoeae to human epithelial cells. Mol. Microbiol. 6:3439-3450[Medline]. |
| 57. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 15.1-15.113. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 58. |
Schnaitman, C. A., and J. D. Klena.
1993.
Genetics of lipopolysaccharide biosynthesis in enteric bacteria.
Microbiol. Rev.
57:655-682 |
| 59. | Schneider, H., A. S. Cross, R. A. Kuschner, D. N. Taylor, J. C. Sadoff, J. W. Boslego, and C. D. Deal. 1995. Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective. J. Infect. Dis. 172:180-185[Medline]. |
| 60. |
Schneider, H.,
J. M. Griffiss,
J. W. Boslego,
P. J. Hitchcock,
K. M. Zahos, and M. A. Apicella.
1991.
Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men.
J. Exp. Med.
174:1601-1605 |
| 61. |
Schneider, H.,
C. A. Hammack,
M. A. Apicella, and J. M. Griffiss.
1988.
Instability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae.
Infect. Immun.
56:942-946 |
| 62. | Schwan, E. T., B. D. Robertson, H. Brade, and J. P. M. van Putten. 1995. Gonococcal rfaF mutants express Rd2 chemotype LPS and do not enter epithelial host cells. Mol. Microbiol. 15:267-275[CrossRef][Medline]. |
| 63. | Seifert, H. S., C. J. Wright, A. E. Jerse, M. S. Cohen, and J. G. Cannon. 1994. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Investig. 93:2744-2749. |
| 64. |
Shaw, J. H., and S. Falkow.
1988.
Model for invasion of human tissue culture cells by Neisseria gonorrhoeae.
Infect. Immun.
56:1625-1632 |
| 65. |
Simon, D., and R. F. Rest.
1992.
Escherichia coli expressing a Neisseria gonorrhoeae opacity-associated outer membrane protein invade human cervical and endometrial epithelial cell lines.
Proc. Natl. Acad. Sci. USA
89:5512-5516 |
| 66. |
Song, W.,
L. Ma,
R. Chen, and D. C. Stein.
2000.
Role of lipooligosaccharide in Opa-independent invasion of Neisseria gonorrhoeae into human epithelial cells.
J. Exp. Med.
191:949-960 |
| 67. | Steeghs, L., R. den Hartog, A. den Boer, B. Zomer, P. Roholl, and P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin. Nature 392:449-450[CrossRef][Medline]. |
| 68. | Stern, A., M. Brown, P. Nickel, and T. F. Meyer. 1986. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell 47:61-71[CrossRef][Medline]. |
| 69. | Swanson, J. 1973. Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. J. Exp. Med. 137:571-589[Abstract]. |
| 70. |
Swanson, J.
1978.
Studies on gonococcus infection. XII. Colony color and opacity variants of gonococci.
Infect. Immun.
19:320-331 |
| 71. | Swanson, J., S. A. Hill, and S. H. Fischer. 1994. Growth on different solid media markedly affects the properties and behaviors of Opa+ gonococci, p. 771-776. In C. J. Conde-Glez, S. A. Morse, P. A. Rice, P. F. Sparling, and E. Calderón (ed.), Pathobiology and immunology of Neisseriaceae. Instituto Nacional de Salud Pública, Cuernavaca, Mexico. |
| 72. | Swanson, J., S. J. Kraus, and E. C. Gotschlich. 1971. Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns, J. Exp. Med. 134:886-906. |
| 73. |
Swanson, J.,
K. Robbins,
O. Barrera,
D. Corwin,
J. W. Boslego,
J. Ciak,
M. S. Blake, and M. Koomey.
1987.
Gonococcal pilin variants in experimental gonorrhea.
J. Exp. Med.
165:1344-1357 |
| 74. |
Towbin, H.,
T. Staehlin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354 |
| 75. | van Dyck, E., A. Z. Meheus, and P. Piot. 1999. Gonorrhoea, p. 1-21. In Laboratory diagnosis of sexually transmitted diseases. World Health Organization, Geneva, Switzerland. |
| 76. | van Putten, J. P. M., S. F. Hayes, and T. D. Duensing. 1997. Natural proteoglycan receptor analogs determine the |